CHE Q3 2024 Earnings — Chemed Corporation Revenue & Financial Results | Market Cap Arena

CHEChemed Corporation

$6B

Q3 2024 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$606M+7.4% YoY

Gross Profit

$210M34.6% margin

Operating Income

$92M15.2% margin

Net Income

$76M12.5% margin

EPS (Diluted)

$5.02

QoQ Revenue Growth

+1.7%

Cash Flow

Operating Cash Flow

$91M

Free Cash Flow

$77M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$534M

Stockholders' Equity

$1.2B

Cash & Equivalents

$238M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$606M	$565M	+7.4%
Gross Profit	$210M	$202M	+3.9%
Operating Income	$92M	$87M	+6.1%
Net Income	$76M	$75M	+1.1%

Revenue Segments

Care Services Total

$394M50%

Routine Home Care

$338M43%

Inpatient Care

$30M4%

Continuous Care

$26M3%

All Other Revenue Self Pay Respite Care Ect.

$5M1%